Vulvar Disease in Nigeria Observational Study

Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Vulvar Diseases Dermatoses Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Skin Diseases Skin and Connective Tissue Diseases Urogenital Diseases Vulvar Atrophy

Age range

10 year–90 year

Sex eligibility

Female

Study type

Observational

Primary location

Kdrs

London, Rm166el, United Kingdom

Location status: Recruiting

Location contact

Dr Adedipe, MRCOG

PRINCIPAL_INVESTIGATOR

Lead Research officer

CONTACT

[email protected]

00447984470726

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

biological females - afab

Exclusion criteria

none-afab

Treatment and study plan

observation

Other

Observing for disease prevalence - actual and self-reported

Primary outcomes

Prevalence of Vulvar disease

Time frame: 1-12 months

Awareness of Vulvar disease (descriptor)

Sponsors and collaborators

Lead sponsor

KDRS ltd

Industry

Registry information

Official study title

Vulvar Disease in Nigeria - Registry ( Observationsl Study)

Acronym: VdiN

Important dates

Study start: 2023
Primary completion: 2026
Study completion: 2026
First posted: Jun 6, 2023
Registry last updated: Jun 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting